All major Covid 19 vaccines have been developed against the original strain of SARS CoV-2. While these have proved highly effective, they need to be reinvented to combat newer variants like Omicron which has the potential to escape vaccine immunity.
According to Unicef's head of supply Etleva Kadilli, more than 100 million vaccines were, in December alone, rejected by countries as they were unable to distribute them, BBC reported.
Meanwhile, the doors of Srimandir have remained closed for the public since January 10. The shrine will remain shut till January 31 in view of the rising cases of Coronavirus in the State and also the detection of some cases in the shrine.
The next phase of COVID-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.
As many 5,25,35,282 vaccine doses have been administered to the people of the State so far. While 91.6 percent have received the first dose and 68 per cent have received both doses, further informed Panigrahi.
Moderna is currently also developing a vaccine to specifically tackle the Omicron variant. Early-stage data on its effectiveness is expected within the next two weeks.
Vaccination process of third precautionary dose for health workers, frontline workers and vulnerable senior citizens is scheduled to start nationwide from January 10.
84-YO Bihar Man Takes 11 Covid Vaccine Shots
Health Minister Mansukh Mandaviya On Country’s Covid Preparedness
As per the study, of the 112 subjects, 11 did not develop antibodies even a month after receiving the first jab. On the other hand, the antibody level in 7 persons had considerably reduced after 6 months of receiving the 2nd dose of Covishield vaccine, found the study.
Adding another feather in the cap of India’s vaccination drive, the much-awaited inoculation of teenagers in the 15-18 years age group kicked off across the country on Monday (January 3). About 42 lakh children in the age group were inoculated on the first day of Covid vaccination.
As many as 35 vaccination centres have been opened for the inoculation of 15 to 18 year olds in Bhubaneswar, the State capital of Odisha.
Mandaviya visited the RT-PCR screening centre at the Ahmedabad international airport in Gujarat and interacted with passengers and officials.
Serum Institute produces AstraZeneca's Covid-19 vaccine under the brand name Covishield. The vaccine is one of India's two main vaccines against Covid pandemic under mass vaccination drive.
No serious adverse event was reported. 374 subjects reported either mild or moderate severity symptoms with 78.6 per cent getting resolved within one day.